Challenges With PARP Inhibitors in Ovarian Cancer

August 16, 2017
Kathleen N. Moore, MD

Kathleen N. Moore, MD, assistant professor in the section of gynecologic oncology and director of the Oklahoma TSET Phase I Clinical Trials Program at the University of Oklahoma Health Sciences Center, discusses challenges with PARP inhibitors in ovarian cancer.